Spontaneous regression in non-Hodgkin's lymphoma: clinical and pathogenetic considerations.

The spontaneous regression (SR) of tumor has been noted in a variety of neoplastic conditions. In non-Hodgkin's lymphoma, this phenomenon has been reported in indolent histologic subtypes, with a frequency of 10-20% in selected series. Investigators evaluating new therapies for lymphomas with a favorable histology need to be cognizant of SR's impact… CONTINUE READING